NCT00024440View on ClinicalTrials.gov

Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2001

Study Completion Date

February 28, 2007

Conditions

Leukemia

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

oblimersen sodium

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

Trial Locations (1)

07922

Genta Incorporated, Berkeley Heights

Sponsors

Lead Sponsor

Genta Incorporated

All Listed Sponsors

lead

Genta Incorporated

INDUSTRY

NCT00024440 - Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter